Project Grant HT94252510572
Award Date
7/15/25
Completion Date
7/14/28
Dollars Obligated
$240K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Australia
Similar Awards
The University of Sydney was awarded a $919,739 Project Grant from the Department of the Army Medical Command through its Military Medical Research and Development program (CFDA 12.420). The grant will fund a molecular epidemiological study from September 2021 through September 2025 examining the relationship between aspirin and NSAID use and ovarian cancer prognosis. The Military Medical Research and Development program aims to transform military and public health through innovative medical...
This Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) provides $591,096.00 in funding to St. Vincent's Institute of Medical Research, a foreign-owned non-profit organization based in Australia. The award supports research focused on the "Prevention of Bone Marrow Failure in Fanconi Anemia through FANCM Inhibition", with a performance period from Jul 15, 2025 to Jul 14, 2028. This research project...
This federal Project Grant award of $632,080.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at the University of Sydney in Australia examining what factors may endow women with a better chance of survival from melanoma. The project has a performance period from July 1, 2025 to June 30, 2028. As a leading Australian educational institution, the University of Sydney has a strong track record of securing federal...
The Department of the Army Medical Command awarded a $1,124,030 Project Grant to St. Vincent's Institute Of Medical Research in Australia to support research titled "IN VIVO DELIVERY OF PRECISE GENE CORRECTION FOR TREATMENT OF FANCONI ANEMIA" from July 1, 2022 through August 31, 2025. The award is being made under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research aimed at transforming healthcare for...
The University of Technology Sydney was awarded a $529,265 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research to identify novel circular RNA biomarkers detectable in blood plasma that can help facilitate the diagnosis of malignant pleural mesothelioma. The research will be performed from September 2022 through September 2025. The Military Medical Research and Development...
The University of New South Wales (UNSW) was awarded a $2,059,003.85 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. Specifically, the funding will enable UNSW to conduct research aimed at understanding and overcoming resistance to new and emerging therapies in...
The Department of the Army Medical Command awarded a $519,702 Project Grant to Stanford University under the Military Medical Research and Development program (CFDA 12.420). The two-year grant will support Stanford's development of non-genotoxic hematopoietic stem cell transplantation regimens for Fanconi anemia. Fanconi anemia is a rare genetic disorder that can cause bone marrow failure and blood cancers. The Military Medical Research and Development program aims to advance medical solutions...
The University of Adelaide in Australia was awarded a $1,005,845 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from September 2022 through September 2025 to exploit prostate cancer metabolic dependencies to develop new therapeutics and circulating prognostic and predictive biomarkers. The Military Medical Research and Development program supports basic, applied, and...
This $1,352,341 Project Grant award, provided by the U.S. Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, will fund a study on the comparative effectiveness of exercise, cognitive behavioral therapy, and their combination for individuals with chronic musculoskeletal pain and poor sleep. The research will be conducted by the University of Sydney in Australia, with a performance period from September 30, 2024 to September 29,...
The Department of the Army Medical Command awarded $608,341 to Monash University under the Military Medical Research and Development federal grant program (CFDA 12.420) from September 15, 2022 through September 14, 2025. The project grant funding will support Monash University's research efforts to elucidate and suppress cells of origin of cutaneous melanoma. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...